199 related articles for article (PubMed ID: 32913893)
21. Human leukocyte antigen (HLA) class II peptide flanking residues tune the immunogenicity of a human tumor-derived epitope.
MacLachlan BJ; Dolton G; Papakyriakou A; Greenshields-Watson A; Mason GH; Schauenburg A; Besneux M; Szomolay B; Elliott T; Sewell AK; Gallimore A; Rizkallah P; Cole DK; Godkin A
J Biol Chem; 2019 Dec; 294(52):20246-20258. PubMed ID: 31619516
[TBL] [Abstract][Full Text] [Related]
22. The study of high-affinity TCRs reveals duality in T cell recognition of antigen: specificity and degeneracy.
Donermeyer DL; Weber KS; Kranz DM; Allen PM
J Immunol; 2006 Nov; 177(10):6911-9. PubMed ID: 17082606
[TBL] [Abstract][Full Text] [Related]
23. Crystal structures of high affinity human T-cell receptors bound to peptide major histocompatibility complex reveal native diagonal binding geometry.
Sami M; Rizkallah PJ; Dunn S; Molloy P; Moysey R; Vuidepot A; Baston E; Todorov P; Li Y; Gao F; Boulter JM; Jakobsen BK
Protein Eng Des Sel; 2007 Aug; 20(8):397-403. PubMed ID: 17644531
[TBL] [Abstract][Full Text] [Related]
24. Direct molecular mimicry enables off-target cardiovascular toxicity by an enhanced affinity TCR designed for cancer immunotherapy.
Raman MC; Rizkallah PJ; Simmons R; Donnellan Z; Dukes J; Bossi G; Le Provost GS; Todorov P; Baston E; Hickman E; Mahon T; Hassan N; Vuidepot A; Sami M; Cole DK; Jakobsen BK
Sci Rep; 2016 Jan; 6():18851. PubMed ID: 26758806
[TBL] [Abstract][Full Text] [Related]
25. Unconventional modes of peptide-HLA-I presentation change the rules of TCR engagement.
Hopkins JR; MacLachlan BJ; Harper S; Sewell AK; Cole DK
Discov Immunol; 2022; 1(1):kyac001. PubMed ID: 38566908
[TBL] [Abstract][Full Text] [Related]
26. Engineering improved T cell receptors using an alanine-scan guided T cell display selection system.
Malecek K; Zhong S; McGary K; Yu C; Huang K; Johnson LA; Rosenberg SA; Krogsgaard M
J Immunol Methods; 2013 Jun; 392(1-2):1-11. PubMed ID: 23500145
[TBL] [Abstract][Full Text] [Related]
27. High-affinity CD8 variants enhance the sensitivity of pMHCI antigen recognition via low-affinity TCRs.
Knezevic L; Wachsmann TLA; Francis O; Dockree T; Bridgeman JS; Wouters A; de Wet B; Cole DK; Clement M; McLaren JE; Gostick E; Ladell K; Llewellyn-Lacey S; Price DA; van den Berg HA; Tabi Z; Sessions RB; Heemskerk MHM; Wooldridge L
J Biol Chem; 2023 Aug; 299(8):104981. PubMed ID: 37390984
[TBL] [Abstract][Full Text] [Related]
28. High-affinity oligoclonal TCRs define effective adoptive T cell therapy targeting mutant KRAS-G12D.
Sim MJW; Lu J; Spencer M; Hopkins F; Tran E; Rosenberg SA; Long EO; Sun PD
Proc Natl Acad Sci U S A; 2020 Jun; 117(23):12826-12835. PubMed ID: 32461371
[TBL] [Abstract][Full Text] [Related]
29. Creating an Innovative Artificial Intelligence-Based Technology (TCRact) for Designing and Optimizing T Cell Receptors for Use in Cancer Immunotherapies: Protocol for an Observational Trial.
Bujak J; Kłęk S; Balawejder M; Kociniak A; Wilkus K; Szatanek R; Orzeszko Z; Welanyk J; Torbicz G; Jęckowski M; Kucharczyk T; Wohadlo Ł; Borys M; Stadnik H; Wysocki M; Kayser M; Słomka ME; Kosmowska A; Horbacka K; Gach T; Markowska B; Kowalczyk T; Karoń J; Karczewski M; Szura M; Sanecka-Duin A; Blum A
JMIR Res Protoc; 2023 Jul; 12():e45872. PubMed ID: 37440307
[TBL] [Abstract][Full Text] [Related]
30. A study of CDR3 loop dynamics reveals distinct mechanisms of peptide recognition by T-cell receptors exhibiting different levels of cross-reactivity.
Tsuchiya Y; Namiuchi Y; Wako H; Tsurui H
Immunology; 2018 Apr; 153(4):466-478. PubMed ID: 28992359
[TBL] [Abstract][Full Text] [Related]
31. A Molecular Switch Abrogates Glycoprotein 100 (gp100) T-cell Receptor (TCR) Targeting of a Human Melanoma Antigen.
Bianchi V; Bulek A; Fuller A; Lloyd A; Attaf M; Rizkallah PJ; Dolton G; Sewell AK; Cole DK
J Biol Chem; 2016 Apr; 291(17):8951-9. PubMed ID: 26917722
[TBL] [Abstract][Full Text] [Related]
32. Functional analysis of peripheral and intratumoral neoantigen-specific TCRs identified in a patient with melanoma.
Bräunlein E; Lupoli G; Füchsl F; Abualrous ET; de Andrade Krätzig N; Gosmann D; Wietbrock L; Lange S; Engleitner T; Lan H; Audehm S; Effenberger M; Boxberg M; Steiger K; Chang Y; Yu K; Atay C; Bassermann F; Weichert W; Busch DH; Rad R; Freund C; Antes I; Krackhardt AM
J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34518289
[TBL] [Abstract][Full Text] [Related]
33. The energetic basis underpinning T-cell receptor recognition of a super-bulged peptide bound to a major histocompatibility complex class I molecule.
Liu YC; Chen Z; Burrows SR; Purcell AW; McCluskey J; Rossjohn J; Gras S
J Biol Chem; 2012 Apr; 287(15):12267-76. PubMed ID: 22343629
[TBL] [Abstract][Full Text] [Related]
34. Directed evolution of human T-cell receptors with picomolar affinities by phage display.
Li Y; Moysey R; Molloy PE; Vuidepot AL; Mahon T; Baston E; Dunn S; Liddy N; Jacob J; Jakobsen BK; Boulter JM
Nat Biotechnol; 2005 Mar; 23(3):349-54. PubMed ID: 15723046
[TBL] [Abstract][Full Text] [Related]
35. Computational design of the affinity and specificity of a therapeutic T cell receptor.
Pierce BG; Hellman LM; Hossain M; Singh NK; Vander Kooi CW; Weng Z; Baker BM
PLoS Comput Biol; 2014 Feb; 10(2):e1003478. PubMed ID: 24550723
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis E Virus (HEV)-Specific T Cell Receptor Cross-Recognition: Implications for Immunotherapy.
Soon CF; Zhang S; Suneetha PV; Antunes DA; Manns MP; Raha S; Schultze-Florey C; Prinz I; Wedemeyer H; Sällberg Chen M; Cornberg M
Front Immunol; 2019; 10():2076. PubMed ID: 31552033
[TBL] [Abstract][Full Text] [Related]
37. Plasticity in the contribution of T cell receptor variable region residues to binding of peptide-HLA-A2 complexes.
Smith SN; Sommermeyer D; Piepenbrink KH; Blevins SJ; Bernhard H; Uckert W; Baker BM; Kranz DM
J Mol Biol; 2013 Nov; 425(22):4496-507. PubMed ID: 23954306
[TBL] [Abstract][Full Text] [Related]
38. Class II-restricted T cell receptor engineered in vitro for higher affinity retains peptide specificity and function.
Weber KS; Donermeyer DL; Allen PM; Kranz DM
Proc Natl Acad Sci U S A; 2005 Dec; 102(52):19033-8. PubMed ID: 16365315
[TBL] [Abstract][Full Text] [Related]
39. Natural high-avidity T-cell receptor efficiently mediates regression of cancer/testis antigen 83 positive common solid cancers.
Li Q; Hu W; Liao B; Song C; Li L
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35798537
[TBL] [Abstract][Full Text] [Related]
40. T cell receptor binding affinity governs the functional profile of cancer-specific CD8+ T cells.
Tan MP; Gerry AB; Brewer JE; Melchiori L; Bridgeman JS; Bennett AD; Pumphrey NJ; Jakobsen BK; Price DA; Ladell K; Sewell AK
Clin Exp Immunol; 2015 May; 180(2):255-70. PubMed ID: 25496365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
